Omega Healthcare Investors Inc financial data

Symbol
OHI on NYSE
Industry
Real Estate Investment Trusts
Location
303 International Circle,, Suite 200, Hunt Valley, MD
State of incorporation
MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 139 % -10.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 270M shares +10.2%
Common Stock, Shares, Outstanding 268M shares +9.49%
Entity Public Float 7.4B USD +12.1%
Common Stock, Value, Issued 26.8M USD +9.49%
Weighted Average Number of Shares Outstanding, Basic 263M shares +7.22%
Weighted Average Number of Shares Outstanding, Diluted 276M shares +7.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.01B USD +18.3%
General and Administrative Expense 84M USD +6.34%
Income Tax Expense (Benefit) 12M USD +286%
Earnings Per Share, Basic 1.4 USD/shares +44.3%
Earnings Per Share, Diluted 1.37 USD/shares +41.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 342M USD -38.3%
Operating Lease, Right-of-Use Asset 30.2M USD +69.1%
Goodwill 645M USD +0.2%
Assets 9.57B USD +1.56%
Liabilities 5.17B USD -7.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax 62.7M USD +123%
Retained Earnings (Accumulated Deficit) 3.97B USD +9.6%
Stockholders' Equity Attributable to Parent 4.21B USD +14.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.4B USD +14.1%
Liabilities and Equity 9.57B USD +1.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 151M USD +36%
Net Cash Provided by (Used in) Financing Activities -186M USD -11.8%
Net Cash Provided by (Used in) Investing Activities -47.5M USD -1886%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 268M shares +9.49%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -81.7M USD -56.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 360M USD -35.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 58.4M USD -4.95%
Deferred Tax Assets, Valuation Allowance 1.96M USD -3.93%
Deferred Tax Assets, Gross 15.5M USD
Operating Lease, Liability 31.6M USD +65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 383M USD +50.2%
Deferred Tax Assets, Operating Loss Carryforwards 2.05M USD -1.49%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 12.1M USD +278%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 7.48B USD +12.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 302M USD -7.94%
Share-based Payment Arrangement, Expense 36.3M USD +10%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%